2 years ago By Suzana — Following a deal first announced in September, Merck (NYSE:MRK) says it has successfully completed the acquisition of Acceleron Pharma (NASDAQ:XLRN). "This

2 years ago By Bryan — Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endoc

3 years ago By Alexdemarco — The September S&P 500 pullback continued with another sharp decline to close out a disappointing month for investors. On Thursday, the Dow Jones Industrial

3 years ago By Gomez — Merck & Co Inc., the Kenilworth, New Jersey-headquartered American multinational pharmaceutical company initially established in Germany by a Merck family

3 years ago By Vivian — A version of Instagram designed for children isn't getting a lot of likes in Washington, D.C. The social media giant said Monday it would suspend its plans

3 years ago By Olachi — Merck, the pharmaceutical giant with sizable operations in West Point, is acquiring Acceleron Pharma for around $11.5 billion, according to a staff report

3 years ago By Flemming — Wall Street stocks were mixed early Friday following a promising announcement from Merck on a therapeutic for Covid-19 as US data showed another rise in in

3 years ago By Tarikul — (Reuters) -Merck & Co said on Thursday it would buy Acceleron Pharma (NASDAQ:XLRN) Inc for about $11.5 billion, broadening its portfolio beyond aging cance

3 years ago By Vivian — Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and hear

3 years ago By Martin — Merck & Co. (MRK) - Get Merck & Co., Inc. (MRK) Report agreed to buy Acceleron Pharma Inc. (XLRN) - Get Acceleron Pharma Inc Report Thursday in a deal that